These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry. Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585 [TBL] [Abstract][Full Text] [Related]
4. TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis. Galoczova M; Nenutil R; Pokorna Z; Vojtesek B; Coates PJ Virchows Arch; 2021 Apr; 478(4):627-636. PubMed ID: 33037932 [TBL] [Abstract][Full Text] [Related]
5. ΔNp63 regulates cell proliferation, differentiation, adhesion, and migration in the BL2 subtype of basal-like breast cancer. Orzol P; Nekulova M; Holcakova J; Muller P; Votesek B; Coates PJ Tumour Biol; 2016 Aug; 37(8):10133-40. PubMed ID: 26825981 [TBL] [Abstract][Full Text] [Related]
6. Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls. Alkhayyat R; Abbas A; Quinn CM; Rakha EA Histopathology; 2024 Apr; 84(5):723-741. PubMed ID: 38012539 [TBL] [Abstract][Full Text] [Related]
7. Frequent alteration of p63 expression in human primary bladder carcinomas. Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040 [TBL] [Abstract][Full Text] [Related]
8. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis. Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901 [TBL] [Abstract][Full Text] [Related]
9. The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer. Buckley NE; Conlon SJ; Jirstrom K; Kay EW; Crawford NT; O'Grady A; Sheehan K; Mc Dade SS; Wang CW; McCance DJ; Johnston PG; Kennedy RD; Harkin DP; Mullan PB Cancer Res; 2011 Mar; 71(5):1933-44. PubMed ID: 21363924 [TBL] [Abstract][Full Text] [Related]
11. A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissues. Sethi I; Romano RA; Gluck C; Smalley K; Vojtesek B; Buck MJ; Sinha S BMC Genomics; 2015 Aug; 16():584. PubMed ID: 26251276 [TBL] [Abstract][Full Text] [Related]
12. Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors. Vakonaki E; Soulitzis N; Sifakis S; Papadogianni D; Koutroulakis D; Spandidos DA J Cancer Res Clin Oncol; 2012 Aug; 138(8):1271-8. PubMed ID: 22441934 [TBL] [Abstract][Full Text] [Related]
13. ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER Liu Y; Nekulova M; Nenutil R; Horakova I; Appleyard MV; Murray K; Holcakova J; Galoczova M; Quinlan P; Jordan LB; Purdie CA; Vojtesek B; Thompson AM; Coates PJ J Pathol Clin Res; 2020 Jan; 6(1):83-93. PubMed ID: 31591823 [TBL] [Abstract][Full Text] [Related]
14. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas. Chen YK; Hsue SS; Lin LM Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414 [TBL] [Abstract][Full Text] [Related]
15. ΔNp63α expression induces loss of cell adhesion in triple-negative breast cancer cells. Nekulova M; Holcakova J; Gu X; Hrabal V; Galtsidis S; Orzol P; Liu Y; Logotheti S; Zoumpourlis V; Nylander K; Coates PJ; Vojtesek B BMC Cancer; 2016 Oct; 16(1):782. PubMed ID: 27724925 [TBL] [Abstract][Full Text] [Related]
16. ΔNp63 activates EGFR signaling to induce loss of adhesion in triple-negative basal-like breast cancer cells. Holcakova J; Nekulova M; Orzol P; Nenutil R; Podhorec J; Svoboda M; Dvorakova P; Pjechova M; Hernychova L; Vojtesek B; Coates PJ Breast Cancer Res Treat; 2017 Jun; 163(3):475-484. PubMed ID: 28349272 [TBL] [Abstract][Full Text] [Related]
17. TAp63 and DeltaNp63 in cancer and epidermal development. Candi E; Dinsdale D; Rufini A; Salomoni P; Knight RA; Mueller M; Krammer PH; Melino G Cell Cycle; 2007 Feb; 6(3):274-85. PubMed ID: 17264681 [TBL] [Abstract][Full Text] [Related]
18. DNA Demethylation Switches Oncogenic ΔNp63 to Tumor Suppressive TAp63 in Squamous Cell Carcinoma. Pokorna Z; Hrabal V; Tichy V; Vojtesek B; Coates PJ Front Oncol; 2022; 12():924354. PubMed ID: 35912167 [TBL] [Abstract][Full Text] [Related]
19. High expression of p63 is correlated to poor prognosis in squamous cell carcinoma of the tongue. Loljung L; Coates PJ; Nekulova M; Laurell G; Wahlgren M; Wilms T; Widlöf M; Hansel A; Nylander K J Oral Pathol Med; 2014 Jan; 43(1):14-9. PubMed ID: 23607508 [TBL] [Abstract][Full Text] [Related]
20. [The two faces of p63, Janus of the p53 gene family]. Caron de Fromentel C; Aberdam E; Aberdam D Med Sci (Paris); 2012 Apr; 28(4):381-7. PubMed ID: 22549865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]